Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

AGA can occur in children with family history; early diagnosis and treatment important.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Trichoscopy is a quick, cost-effective tool for diagnosing different hair loss conditions.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Shampoos are designed to clean and improve hair and scalp health, with specific ingredients for different hair types and conditions.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Hair transplant destroyed by lichen planopilaris.

Sunlight worsens hair loss; protect scalp.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Human hair's ability to get wet is complex and can change with treatments, damage, and environment.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Trichoscopy is a non-invasive way to diagnose hair and scalp problems without needing hair samples.

Hair follicles can help wounds heal faster and this knowledge could be used to treat chronic skin ulcers, with a potential use of a special stem cell hydrogel to enhance healing.

Infrared and Raman imaging can non-destructively analyze hair structure and help diagnose hair conditions.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.